NexGel, Inc Warrant 2021-01.12.26 on NexGelNexGel, Inc Warrant 2021-01.12.26 on NexGelNexGel, Inc Warrant 2021-01.12.26 on NexGel

NexGel, Inc Warrant 2021-01.12.26 on NexGel

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪23.65 M‬USD
−0.4019USD
‪−3.28 M‬USD
‪8.69 M‬USD
‪6.47 M‬
Beta (1Y)
0.71

About NexGel, Inc


CEO
Adam D. Levy
Website
Headquarters
Langhorne
Founded
2009
ISIN
US65344E1156
FIGI
BBG0142NKTM7
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It operates through the NexGel and CGN segments. The NexGel segment consists of the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. The CGN segment consists of the CGN JV used for the company’s converting and packaging business, which is based in Granbury, Texas. The company was founded on January 13, 2009, and is headquartered in Langhorne, PA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.